Roche Holding AG RHHBY OTC · Healthcare · Switzerland
$60.29 -1.08% -$0.66
Summary
68 / 100 · Bulios Score
What speaks for it
- Out of every 100 CHF of revenue, 20 CHF is left as net profit.
- It earns 20 CHF a year on every 100 CHF of invested capital.
- The share price is below the Bulios Fair Price.
What to watch
- Revenue fell by 1.3% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBy our assumptions the business is worth more than its shares cost today.
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 25.2 CHF for 1 CHF of yearly profit. Over the last five years it was 20.8 CHF on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (CHF)
Diluted EPS (CHF)
- Analyst estimate
Revenue grew by 1.7% a year over 5 years. Over the last 3 years it fell by 1.3% a year. For the next fiscal year analysts expect revenue to fall by 2.1%. Earnings per share fell by 0.2% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 2.57%
- Paid out of profit
- 65%
You receive $1.55 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 3
- Hold 5
- Sell 1
Today's price within the analysts' price targets
The average target of $63 is 4.5% above today's price. 33% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.